Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2-Reference-Cited by-同舟云学术

Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2

Published:2020-09 Issue: Volume:252 Page:7-14
ISSN:0301-2115
Container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology
language:en
Short-container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology

Author:

Gemzell-Danielsson Kristina^ORCID,Heikinheimo Oskari,Zatik Janos,Poka Robert^ORCID,Rechberger Tomasz,Hudecek Robert,Petersdorf Kathrin,Ramirez Francisco,Faustmann Thomas,Groettrup-Wolfers Esther,Seitz Christian

Funder

Bayer AG, Berlin, Germany

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference36 articles.

1. The impact of uterine leiomyomas: a national survey of affected women;Borah;Am J Obstet Gynecol,2013

2. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence;Baird;Am J Obstet Gynecol,2003

3. Epidemiology of uterine fibroids: a systematic review;Stewart;BJOG,2017

4. The management of uterine leiomyomas;Vilos;J Obstet Gynaecol Can,2015

5. Clinical presentation of fibroids;Gupta;Pract Res Obstet Gynecol,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial;F&S Reports;2024-06

2. Experimental and new investigational drugs for the treatment of uterine fibroids;Expert Opinion on Investigational Drugs;2024-04-17

3. Current and Emerging Treatment Options for Uterine Fibroids;Drugs;2023-11-03

4. Efficacy and safety of vilaprisan in women with uterine fibroids: data from the ASTEROID 3 randomized controlled trial;F&S Science;2023-11

5. Terapias emergentes en el tratamiento médico de los miomas uterinos;Medicina Clínica;2023-10